“entrectinib” Archives

in
Entry Author Date Location
Eying “Extra” DNA As Cancer Driver, Boundless Bio Debuts With $46M 09/19/19 San Diego
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work 03/06/19 San Diego
With $42M, Ex-Ignyta CEO Aims At Cancer Again With Startup, Erasca 12/18/18 San Diego
Genetic Medicine: FDA OKs 2nd Cancer Drug That Targets DNA, Not Tissues 11/26/18 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Another Precision Step for Roche as Ignyta Drug Heads to Regulators 09/24/18 San Francisco
Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More 07/20/18 National
Trump v. Drug Makers? And 6 More Burning Biopharma Questions for 2018 01/02/18 National
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal 12/22/17 San Diego
In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs 11/14/17 New York
West Coast Biotech Roundup: Laguna, SeaGen, Unchained, DME & More 02/19/15 San Francisco
Page 1 of 1